Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Everest Medicines Ltd. (HK:1952)
HKEX:1952
Holding HK:1952?
Track your performance easily
1952 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$14.34 - HK$32.20
Previous CloseHK$22.45
Volume461.91K
Average Volume (3M)1.57M
Market Cap
HK$7.30B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.89
Next Earnings
Mar 27, 2025EPS Estimate
-HK$1.17Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.56
Shares OutstandingN/A
10 Day Avg. Volume2,102,238
30 Day Avg. Volume1,569,176
Standard Deviation0.30
R-Squared0.43
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)294.46
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$25.00Price Target Upside11.36% Upside
Rating ConsensusHold
Number of Analyst Covering1
Everest Medicines Ltd. News
PremiumCompany Announcements
Everest Medicines Announces Mid-Year Financials
PremiumCompany Announcements
Everest Medicines Schedules Key Financial Review Meeting
PremiumCompany Announcements
Everest Medicines Shareholders Approve Key Resolutions
PremiumCompany Announcements
Everest Medicines Ltd. Prepares for AGM 2024Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
2.06% Mutual Funds
2.06% Other Institutional Investors
95.88% Public Companies and
Individual Investors
1952 FAQ
What was Everest Medicines Ltd.’s price range in the past 12 months?
Everest Medicines Ltd. lowest stock price was HK$14.34 and its highest was HK$32.20 in the past 12 months.
What is Everest Medicines Ltd.’s market cap?
Currently, no data Available
When is Everest Medicines Ltd.’s upcoming earnings report date?
Everest Medicines Ltd.’s upcoming earnings report date is Mar 27, 2025 which is in 188 days.
How were Everest Medicines Ltd.’s earnings last quarter?
Everest Medicines Ltd. released its earnings results on Aug 28, 2024. The company reported -HK$2.166 earnings per share for the quarter, missing the consensus estimate of -HK$1.11 by -HK$1.055.
Is Everest Medicines Ltd. overvalued?
According to Wall Street analysts Everest Medicines Ltd.’s price is currently Undervalued.
Does Everest Medicines Ltd. pay dividends?
Everest Medicines Ltd. does not currently pay dividends.
What is Everest Medicines Ltd.’s EPS estimate?
Everest Medicines Ltd.’s EPS estimate is -HK$1.17.
How many shares outstanding does Everest Medicines Ltd. have?
Everest Medicines Ltd. has 325,189,300 shares outstanding.
What happened to Everest Medicines Ltd.’s price movement after its last earnings report?
Everest Medicines Ltd. reported an EPS of -HK$2.166 in its last earnings report, missing expectations of -HK$1.11. Following the earnings report the stock price went down -0.238%.
Which hedge fund is a major shareholder of Everest Medicines Ltd.?
Currently, no hedge funds are holding shares in HK:1952
---
Everest Medicines Ltd. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
-21.54%
Trailing 12-Months
Asset Growth
-12.50%
Trailing 12-Months
Company Description
Everest Medicines Ltd.
Everest Medicines Ltd is a biopharmaceutical company that integrates licensing, clinical development, and commercialization of potentially globally therapies to address critical unmet medical needs in Greater China and other emerging Asia Pacific markets. The company has assembled a portfolio of eight clinical-stage drug candidates for oncology, immunology, cardio-renal disease, and infectious disease.
---
1952 Stock 12 Month Forecast
Average Price Target
HK$25.00
▲(11.36% Upside)
Technical Analysis
Times Neighborhood Holdings Ltd.
―
AK Medical Holdings Ltd.
―
Viva Biotech Holdings
―
Kintor Pharmaceutical Ltd
―
---